Choo P H, Carter S R, Crawford J B, Seiff S R
Department of Ophthalmology, University of California Davis, Sacramento, USA.
Ophthalmic Plast Reconstr Surg. 1999 Mar;15(2):77-8. doi: 10.1097/00002341-199903000-00002.
Hydroxyapatite (HA) spheres used to replace volume after an enucleation are often wrapped with autologous tissue before orbital implantation. Man-made materials are less expensive and pose no risk for viral transmission. The use of expanded polytetrafluoroethylene (ePTFE) to wrap HA spheres was evaluated.
The medical records of 2 consecutive patients who underwent uncomplicated implantation of an HA sphere wrapped in ePTFE were reviewed.
An unusual reaction to the ePTFE material that was nonresponsive to topical or systemic antibiotic therapy developed in these 2 patients. Eventual wound erosion and bacterial infection of the implant necessitated its removal.
Although well tolerated in other surgeries, ePTFE, when used to wrap HA spheres and placed into the orbit, may cause persistent conjunctival discharge, pyogenic granuloma formation, and eventual wound erosion. Therefore, the use of this material to wrap HA spheres is not recommended.
眼球摘除术后用于填充眼眶容积的羟基磷灰石(HA)球在眼眶植入前通常用自体组织包裹。人造材料成本较低且无病毒传播风险。本研究评估了用膨体聚四氟乙烯(ePTFE)包裹HA球的应用情况。
回顾性分析2例连续接受ePTFE包裹HA球植入且手术过程顺利患者的病历资料。
这2例患者对ePTFE材料出现异常反应,局部或全身应用抗生素治疗均无效。最终,植入物出现伤口糜烂和细菌感染,不得不将其取出。
尽管ePTFE在其他手术中耐受性良好,但用于包裹HA球并植入眼眶时,可能会导致持续性结膜分泌物、脓性肉芽肿形成以及最终的伤口糜烂。因此,不建议使用这种材料包裹HA球。